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There is compelling evidence that central sensitization (CS) is pres­ent in a subgroup of people with 
knee osteoarthritis (OA) pain, especially 
in those with more advanced knee OA, 
and may be associated with knee OA 
symptom severity. 1 2 According to 
Woolf, CS is “operationally defined as an 
amplification of neural signaling within 
the central nervous system that elicits 
pain hypersensitivity. ”3<f  s4) Central sen­
sitization is a broad concept encompass­
ing numerous and complex pathophysi­
ological mechanisms, such as spinal cord 
sensitization, impaired functioning of 
brain-orchestrated descending antinoci­
ceptive (inhibitory) mechanisms, overac­
tivation of descending pain facilitatory 
pathways, increased temporal summa­
tion (TS), or wind-up and alteration of 
sensory processing in the brain.3
If present in people with knee OA pain, 
CS may mediate treatment responses. For 
instance, the presence of preoperative 
CS (eg, widespread pain sensitization, 
enhanced TS of pain) was associated 
with poor outcomes after total knee 
replacement.4 ’5 Therefore, it may be 
important for clinicians to identify CS in 
people with knee OA pain. In such 
patients, a broader therapeutic approach 
aiming to desensitize the central nervous 
system seems warranted.6
Several methods for assessing CS in peo­
ple with knee OA pain are available. 
However, they are typically performed 
within laboratory conditions, including 
brain imaging techniques,7B psycho­
physical testing with various stimuli (eg, 
quantitative sensory testing [QST]910), 
and cerebral metabolism studies." Cur­
rently, there is a lack of established cri­
teria for the clinical diagnosis of CS in 
knee OA. 12 Laboratory-based measures 
such as the nociceptive flexor reflex13 or 
laser-evoked potentials provide more 
objective evidence for hyperexcitability 
of central nervous system neurons, but 
no single measure can be regarded as the 
“gold standard” for establishing CS in 
knee OA. The lack of a gold standard may 
be due to the complexity and diversity of 
the underlying mechanisms.
Recently, a set of criteria to assist clini­
cians on the classification of CS pain has
been published. 14 but the suitability of 
tills classification algorithm to the OA 
knee pain population is unknown. One 
criterion included for the classification of 
CS pain is diffuse pain distribution (ie, 
large pain areas with a neuroanatomi- 
cally illogical distribution) as identified 
from the clinical history and/or a body 
chart. 14 Expanded distribution of pain is 
a well-recognized sign of CS, 12 15 16 and, 
in this regard, pain drawings might be 
useful to identify extended areas of pain 
distribution in people with knee OA
Pain drawings have been used to obtain a 
graphic representation of pain location 
and distribution in people with knee OA 
pain. 17 23 In pain drawings, the patient 
or clinician indicates the location of pain 
by shading the painful area.24 Several 
methods and instruments have been 
described to record the pain location and 
classify the pattern of knee OA pain, and 
the most common method is asking peo­
ple to draw where they feel pain on a 
body chart.171 9 '20 Based on studies inves­
tigating pain drawings in individuals with 
knee OA pain, the medial knee region 
appears to be the most frequently 
reported pain location among people 
with knee OA pain, 19-20-25 26 although 
generalized or diffuse knee pain also is 
commonly reported . 1719  However, the 
location of pain is heterogeneous, with 
no single pattern of pain location being 
pathognomonic for knee OA. 19 which 
might be due to the multiple sources of 
pain (eg. stretched ligaments, subchon­
dral bone damage, bone marrow lesions) 
in knee OA.20
Recently, the presence of widespread 
pain as recorded on pain drawings was 
most frequently reported by a subgroup 
of individuals with high levels of knee 
OA pain (particularly bilateral pain) and 
low levels of structural damage on radi­
ography (eg, grades I and II on the 
Kellgren-Lawrence grading system for 
OA) . 27 Enlarged areas of pain in this sub­
group were attributed to a variety of eti­
ological factors, including abnormal cen­
tral pain processing mechanisms. Wood 
and colleagues19 found that people with 
knee OA reporting enlarged areas of pain 
had more persistent and severe pain and 
higher anxiety levels, which also was 
interpreted as reflecting altered central
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pain processing mechanisms. However, 
it must be emphasized that, in the above- 
mentioned studies, CS was only hypoth­
esized as the explanation of the study 
findings, and no attempts were made to 
directly measure CS.
To our knowledge, only the above- 
mentioned studies1927 related central 
pain mechanisms to individuals’ record­
ing of symptom location and distribution 
in people with knee OA pain. If CS was 
the dominant pain mechanism in an indi­
vidual with knee OA pain, this finding 
should be reflected in more extended 
areas of pain mapped in pain drawings 
compared with people with a lesser 
degree of pain sensitization.22
Therefore, the primary aim of this study 
was to examine whether the area of pain 
assessed using pain drawings relates to 
direct (QST) and indirect (self-report 
questionnaires, neuropathic pain) mea­
sures of CS in people with different 
degrees of chronic knee OA pain. As 
opposed to quantitative pain assessment 
tools, which provide direct evidence of 
CS in chronic joint pain,91012 indirect 
measures of CS (eg, self-report question­
naires designed to determine presence of 
neuropathic pain) offer only indirect evi­
dence of hypersensitivity of the central 
nervous system in people with knee OA 
pain.1-14'28 As a secondary aim, the asso­
ciation between the area of pain and clin­
ical symptoms (including the level of 
knee pain, disability, and psychosocial 
variables) also was investigated. Psycho­
social factors (eg, cognitions and beliefs 
about pain) may explain some of the 
variation in pain reporting among indi­
viduals with knee OA.29 For instance, cat­
astrophic thinking and poor coping strat­
egies in people with knee OA pain can 
predict the presence of more pain after 
total knee replacement surgery.4
Method
Participants
A convenience sample of 53 people with 
chronic knee OA pain of more than 3 
months’ duration who were scheduled 
to undergo primary total knee arthro­
plasty participated in the study. People 
with knee OA affecting the tibiofemoral 
and patellofemoral compartments were 
included. These individuals partici­
pated in a randomized controlled trial 
investigating the effects of pain neurosci­
ence education on pain and function 
in people with chronic knee OA 
pain (ClinicalTrials.gov identifier 
NCT02246088). Baseline data from the 
entire cohort were used for this study. 
All participants were recruited from the 
Orthopedic Surgery Service of the Hos­
pital Universitario de La Ribera (Alzira, 
Spain) between January 2014 and Febru­
ary 2015.
All participants underwent weight­
bearing, fixed flexion posteroanterior 
and lateral radiographs of their affected 
knee. Radiographic disease severity of 
both the tibiofemoral (Kellgren- 
Lawrence 0 -4  grading scale-40) and patel­
lofemoral (Ahlback 0-5  grading scale31) 
compartments was evaluated for each 
participant. Knee OA was diagnosed by a 
surgeon according to the American Col­
lege of Rheumatology classification,32 
including the regular experience of knee 
pain, plus either osteophytes on radiog­
raphy or a combination of morning stiff­
ness, crepitus, and age 50 years or above. 
These criteria were found to be 89% sen­
sitive and 88% specific for diagnosing 
knee OA.32
Individuals were excluded from study 
participation if they had previously 
undergone knee joint replacement sur­
gery of the affected joint or any other 
lower limb surgery within the previous 6 
months; had coexisting inflammatory, 
metabolic, neurological, or severe medi­
cal conditions hindering the ability to 
participate in the study; or had cognitive 
disturbances that could influence com­
pletion of the pain drawings. Before 
study participation, all individuals care­
fully read an information leaflet and 
signed informed consent forms.
Procedure
Demographic information, including 
age, sex, body mass index, and pain dura­
tion, were collected by self-report. Par­
ticipants additionally completed an 
11-point numeric rating scale to quantify 
their current pain intensity and were 
asked to complete a pain drawing to 
illustrate their area of pain.
Participants then completed the follow­
ing self-administration questionnaires in 
a standardized order: the Western
Ontario and McMaster Universities 
Arthritis Index (WOMAC), Pain Catastro- 
phizing Scale (PCS), Central Sensitization 
Inventory (CSI), PainDETECT question­
naire (PD-Q), 11-item version of the 
Tampa Scale for Kinesiophobia (TSK-11), 
Pain Vigilance and Awareness Question­
naire (PVAQ), and Chronic Pain Accep­
tance Questionnaire (CPAQ).
Afterward, a standardized physical exam­
ination including physical performance 
tests was performed on each participant. 
Finally, all participants were assessed 
with QST to examine pressure pain 
thresholds (PPTs), TS, and conditioned 
pain modulation (CPM). All QST was car­
ried out by the same researcher in one 
individual session in the laboratories of 
the Hospital Universitario de La Ribera. 
The participants were requested not to 
take analgesic medication 24 hours 
before the experiment. At the time of 
examination, the assessor was blinded to 
the questionnaire data, including analysis 
of the scores obtained with pain draw­
ings. Statistical analysis of the pain draw­
ing data was performed by a researcher 
who was blinded to the QST data.
Measurements of Area of Pain
A novel method for obtaining and quan­
tifying the area of pain with a digital 
tablet was used.33 Test-retest reliability of 
this method for acquisition of pain draw­
ings was recently demonstrated in peo­
ple with chronic neck and low back 
pain.33 Pain drawings were completed 
on a digital tablet (iPad 2, Apple Inc, 
Cupertino, California) using a stylus pen 
for digital tablets (CS100B, Wacom Tech­
nology Corp, Vancouver, Washington) 
and commercially available sketching 
software (SketchBook Pro, Autodesk Inc, 
San Rafael, California). Depending on the 
participant’s sex, a male or female body 
chart with different views of the knee 
region (frontal, dorsal) was chosen and 
opened in the sketching software 
(Fig. 1A). The type, size, and color of the 
pen stroke were standardized across all 
participants.
An operator, who trained with the 
device in clinical practice 1 month prior
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Figure 1.
(A) Example o f the  available tem plates. (B) Pain frequency maps generated separately fo r men and w o m en  by superim posing the  pain 
draw ings o f all ind iv idua ls  w ith  knee osteoarthritis  pain. The co lo r g rid  indicates bo th  the  num ber and the  percentage o f ind iv idua ls  w h o  
reported  pa in in th a t specific area. Dark red represents the  m ost frequ en tly  reported  area o f pain.
to the start of the study, gave each par­
ticipant a standardized verbal explana­
tion of what the pain drawing is and 
how to complete it using the digital tab­
let. The pain drawing was presented to 
participants as a tool where they should 
illustrate precisely where they had felt 
pain during the previous week. The 
assessor highlighted the importance of 
fully illustrating all pain sites. After a 
demonstration and brief training to famil­
iarize the participants with the device, 
they were asked to complete their pain 
drawings. Participants were instructed as 
follows: “Please shade the areas where 
you felt your usual pain during the last
week on this body chart, and try to be 
as precise as possible.” They were 
instructed to color every part of the body 
where they perceived pain in the previ­
ous week, independently from the type 
and the severity of pain. Before saving 
and storing the pain drawing, partici­
pants were asked whether the pain draw­
ing corresponded to their real pain dis­
tribution. If not, they were given the 
possibility to correct the drawing using 
the “eraser” tool.
A custom-designed software program 
was used to compute the total area of
pain for each participant and to generate 
2 pain frequency maps (ie, frontal and 
dorsal body chart) separately for men 
and women.33 The area of pain was 
expressed as the total number of pixels 
colored inside the frontal and dorsal 
body chart perimeter. Thus, the area of 
pain extracted from the dorsal view and 
frontal view were combined to generate 
a single value of area of pain. Pain fre­
quency maps were obtained by superim­
posing the pain drawings from all partic­
ipants to illustrate the most frequently 
reported location of pain across the 
entire sample. This was done for women 
and men separately. A color grid was
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used to indicate the percentage of indi­
viduals who reported pain in that spe­
cific area.
Direct Measures of CS 
PPT. A standardized protocol for eval­
uating PPT was used.34 Two test sites in 
the peripatellar region (3 cm medial and 
lateral to the midpoint of the medial and 
lateral edges of the patella, respectively) 
and one control distant site on the ipsi- 
lateral extensor carpi radialis longus mus­
cle (5 cm distal to lateral epicondyle of 
humerus) were selected for PPT mea­
surement.21 The PPT was measured 
using an analog Fisher algometer (Force 
Dial model FDK 40 Push-Pull Force Gage, 
Wagner Instruments, Greenwich, Con­
necticut) with a surface area at the round 
tip of 1 cm2. The algometer probe tip 
was applied perpendicular to the skin at 
a rate of 1 kg/cm2/s until the first onset 
of pain. Pain pressure threshold was 
measured 3 times on each site, with 
a 30-second interstimulus interval 
between measurements. The mean of 
the 3 measurements was used in the sta­
tistical analysis.
Temporal summation of pain and 
CPM. For measuring excitability of 
nociceptive pathways and efficacy of 
endogenous pain inhibition, the TS and 
CPM paradigms were used. Temporal 
summation and CPM are established 
ways of measuring excitability of nocice­
ptive pathways and pain inhibition, 
respectively.35-36
First, PPTs were measured at the peripa­
tellar region and the ipsilateral extensor 
carpi radialis longus muscle as described 
above. Second, TS was provoked by 
means of 10 consecutive pulses at a pre­
viously determined PPT at each location. 
Temporal summation started 2 minutes 
after PPT measurement. For each pulse, 
pressure was gradually increased at a rate 
of 2 kg/s to the determined PPT and 
maintained for 1 second before being 
released (1-second interstimulus inter­
val). Pain intensity of the 1st, 5th, and 
10th pulses was rated on a numerical 
rating scale (0= “no pain" to 10=“worst 
possible pain”). Afterward, a rest period 
of 5 minutes was given.
Third, CPM was induced by combining 
the TS procedure (namely, the test stim­
ulus) and an inflated occlusion cuff 
around the participant’s arm, contralat­
eral to the side of the affected knee, to a 
painful intensity (conditioning stimulus). 
The occlusion cuff was inflated at a rate 
of 20 mm Hg/s until “the first sensation 
of pain” and maintained for 30 seconds. 
Afterward, pain intensity, as a result of 
cuff inflation, was rated on a numerical 
rating scale. Next, cuff inflation was 
increased or decreased until the pain 
intensity was rated as 3/10. The length of 
time to reach 3/10 pain was recorded. 
Temporal summation assessment was 
then repeated during maintenance of the 
cuff inflation.37 The details and data sup­
porting the test-retest reliability and 
validity of the protocol for examining TS 
and CPM are described elsewhere.37
Indirect Measures of CS 
CSI. The CSI is a self-report screening 
instrument to help identify people with 
central sensitivity syndromes for which 
CS may be a common etiology.38 Part A 
of the CSI assesses symptoms common to 
CS and comprises 25 items, each rated 
on a 5-point scale with the end points 0 
(“never”) and 4 (“always”) (range = 
0-100). The CSI has high reliability and 
validity,38 and a cutoff score of 40 out of 
100 was able to distinguish between indi­
viduals diagnosed with central sensitivity 
syndromes and a nonpatient comparison 
sample (sensitivity=81%, specificity= 
75%).39 The Spanish version of the CSI 
was used in this study.
Neuropathic pain. The Spanish ver­
sion of the PD-Q was used to facilitate 
the identification of neuropathic pain 
related to knee OA.4H Although devel­
oped as a screening questionnaire for 
neuropathic pain, the PD-Q also may 
function as a measure of characteristics 
that indicate augmented central pain pro­
cessing in people with knee OA pain.41
The PD-Q is a self-administered question­
naire comprising 9 items (7 evaluating 
pain quality, 1 evaluating pain pattern, 
and 1 evaluating pain radiation), all of 
which contribute to an aggregate score 
(range= —1 to 38). Sensitivity, specific­
ity, and positive predictive values for 
neuropathic pain symptoms in people
with back pain using the cutoff score of 
19 were 85%, 80%, and 83%, respec­
tively.42 The relationship between PD-Q 
scores and signs of CS in people with hip 
OA has been demonstrated previously.8
Clinical Symptoms 
Self-reported knee pain. Participants 
were asked to indicate the intensity of 
their pain in the last week on a numeric 
rating pain scale ranging front 0 (“no 
pain”) to 10 (“worst pain imaginable”). 
The patient-report numeric rating scale 
has demonstrated good construct valid­
ity and moderate-to-large responsiveness 
(standardized response mean and effect 
size ranging from 0.6 [hip OAJ to 0.9 
[knee OA]) for evaluating functional dis­
ability in people with hip and knee OA.43
Physical performance tests. Range 
of motion for both active knee flexion 
and extension was measured for each 
participant, and each participant per­
formed the Timed “Up & Go” Test. These 
objective measures were selected on the 
basis of their ability to reflect functional 
mobility impairments.
High intratester and intertester reliability 
and criterion validity of goniometry to 
measure range of motion has been doc­
umented for knee flexion and extension 
in people with knee restrictions of dif­
ferent etiologies.44 The Timed “Up & 
Go” Test is a reliable test with adequate 
minimum detectable change for clinical 
use in individuals with doubtful-to- 
moderate (grade 1-3) knee OA.4546 
Intrarater and interrater reliability of the 
Timed “Up & Go” Test were .97 (95% 
confidence interval [Cl] = .95, .98) and 
.96 (95% Cl=.94, .97), respectively. Its 
minimum detectable change, based on 
measurements performed by a single 
rater and between raters, was 1.10 and 
1.14 seconds, respectively.46
WOMAC. The Spanish version of the 
self-administered WOMAC for individu­
als with knee and hip OA was used.17 
The WOMAC comprises 5 items for pain 
(score range=0-20), 2 items for stiffness 
(score range=0-8), and 17 items for 
functional limitation (score range= 
0-68). Total WOMAC score and scores 
from the pain, stiffness, and functional 
limitation subscales were considered.
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Higher scores on the WOMAC indicate 
worse pain, stiffness, and functional lim­
itation. The test-retest reliability (intra­
class correlation coefficients range= 
.66- 81), internal consistency (Cronbach 
alpha range=.81-.93), convergent valid­
ity (Pearson coefficient range= — .52 to 
— .63), and responsiveness (standardized 
response mean range=0.8-1.5) of the 
Spanish version of the WOMAC have 
been demonstrated in people with hip 
and knee OA.*7
PCS. The PCS is a valid and reliable 
instrument to measure pain catastrophiz- 
ing in older adults with knee OA.48-49 It 
comprises 13 items, each rated on a 
5-point scale with the end points 0 (“not 
at all”) and 4 (“all the time”) (range= 
0-52). Higher scores indicate a higher 
degree of pain catastrophizing. The Span­
ish version of the PCS showed appropri­
ate internal consistency (Cronbach 
alpha = .79), test-retest reliability (intra­
class correlation coefficient=.84) and 
sensitivity to change (effect size <2) in 
patients with fibromyalgia.50
TSK -11. The Spanish version of the 
TSK-11 was used.51 The TSK-11 is an 
11 -item questionnaire assessing fear of 
movement or fear of injury or reinjury 
during movement and eliminates psycho- 
metrically poor items from the original 
17-item version of the TSK,52 thus creat­
ing a shorter questionnaire with compa­
rable internal consistency. It comprises 
11 items, each rated on a 4-point scale 
with the end points 1 (“totally agree”) 
and 4 (“totally disagree”) (range= 
11-44). The TSK-11 has a 2-factor struc­
ture (ie, activity avoidance and harm) 
and has demonstrated acceptable 
internal consistency and validity (conver­
gent and predictive) in both people with 
acute musculoskeletal pain (Cronbach 
alpha=.79) and those with chronic 
musculoskeletal pain (Cronbach alpha= 
.79).51 Higher scores indicate more fear- 
avoidance behavior.
PVAQ. The Spanish version of the 
PVAQ was used to evaluate participants’ 
preoccupation with or attention to pain 
associated with pain-related fear and per­
ceived pain severity.53 The PVAQ com­
prises 9 items, each rated on a scale from 
0 (“never”) to 5 (“always”) (range=
0-45). Higher scores indicate a higher 
degree of pain vigilance and awareness. 
Psychometric properties of the PVAQ 
were previously reported in people with 
chronic back pain53 and fibromyal­
gia,54-55 showing good internal consis­
tency,54-55 reliability,53-54 and valid­
ity.53-54 A cutoff score of 24.5 out of 45 
was able to identify women with fibro­
myalgia who had worse daily functioning 
(sensitivity =.71, specificity =.75).54
CPAQ. The CPAQ is the questionnaire 
most often used to measure pain accep­
tance in chronic pain populations.56 The 
CPAQ comprises 20 items, each rated on 
a scale from 0 (“never true”) to 6 
(“always true”) (range=0-120), and it 
has a 2-factor structure: activities engage­
ment and pain willingness. The total 
score results from the sum of these 2 
factors, with higher scores indicating a 
higher degree of chronic pain accep­
tance. The Spanish version of the CPAQ, 
which is reliable (intraclass correlation 
coefficient=.83) and has valid construct 
validity (Cronbach alpha=.83) for peo­
ple with fibromyalgia, was used in this 
study.56
Data Analysis
Distribution of the data was tested with 
the Shapiro-Wilk test, and non-normally 
distributed data were identified. Descrip­
tive statistics were used to describe the 
baseline characteristics of the individuals 
with knee OA pain. A Mann-Wliitney U 
test was run to determine whether there 
were differences in baseline clinical vari­
ables between male and female partici­
pants. Pain frequency maps were gener­
ated by superimposing the scores 
obtained with pain drawings, consider­
ing men and women separately. Tempo­
ral summation was calculated as the dif­
ference percentage between the 1st and 
10th pain rating scores before occlusion 
using the formula: ([TS 10th—TS lst]/TS 
1st) X 100.57 The outcome measure for 
CPM was calculated as the difference 
between the 10th pain rating score 
before occlusion and the 10th pain rating 
score during occlusion.37 Spearman cor­
relation coefficients were computed to 
reveal possible correlations: (1) between 
the area of pain and direct measures of 
CS (ie, PPT knee, PPT epicondyle, knee 
TS, epicondyle TS, knee CPM, and epi­
condyle CPM), (2) between the area of 
pain and indirect measures of CS (ie, CSI 
and PD-Q), and (3) between the area of 
pain and clinical symptoms (ie, visual 
analog scale, WOMAC, WOMAC pain 
subscale, WOMAC stiffness subscale, 
WOMAC functional limitation scale, PCS, 
TSK, PVAQ, and CPAQ). Statistical anal­
yses were performed using I11M SPSS ver­
sion 22 (IBM Corp, Arntonk, New York). 
The significance level was set at P<.05.
Results
Fifty-three individuals with knee OA (34 
woman and 19 men) were enrolled in 
the study. Participants’ demographic 
data are reported in Table 1, and clinical 
characteristics and measurements of CS 
are detailed in Table 2. Mean and median 
scores for the area of pain, range of 
motion for active knee flexion, Timed 
“Up & Go” Test, WOMAC and WOMAC 
pain and functional limitation subscale, 
PCS, CPAQ, TSK, CSI, PD-Q, and PPT at 
the knee were significantly different 
between male and female participants 
(JP<.05). Seven out of the 53 participants 
(13.2%) had scores that correspond to 
likely neuropathic pain (>19 on the 
PD-Q). The mean area of pain was 12,766 
pixels (SD= 13,494) across the entire 
sample, whereas it was 15,012 pixels 
(SD= 14,327) and 8,747 pixels (SD= 
11,096) for women and men, respec­
tively. Pain frequency maps for the 
individuals with knee OA are illustrated 
in Figure IB, and correlations between 
the area of pain and measures of CS 
and clinical symptoms are reported in 
Table 3.
Area of Pain and Direct and 
Indirect Measures of CS
Significant correlations were identified 
between the area of pain and PPT at the 
knee (rs= —.306, PC.05) and epicondyle 
(rs= — .308, P< .05), signifying lower PPT 
at both sites in individuals with larger 
pain areas. Figure 2 illustrates the rela­
tionship between the area of pain and 
the PPT for both knee and epicondyle. 
No significant associations were 
observed between the area of pain and 
TS (rs= -.0183  for knee, r5= -.0 8 7  for 
epicondyle) or the area of pain and CPM 
(rs= —.066 for knee, rs= — .040 for epi­
condyle). A significant correlation was 
identified between the area of pain and
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Table 1.
Partic ipant D em ograph ic  Characteristics"
Baseline Demographic 
Characteristics of 
Patients W ith  OA
All
Participants
(N =53 )
X (SD)
Median (IQR)
Female
Participants
(n = 34 )
X (SD)
Median (IQR)
Male
Participants
(n = 1 9 )
X (SD)
Median (IQR) pb
A ge (y) 70 .2  (7 .4 ) 71 .2  (7 .8 ) 68 .5  (6 .3 )
.130
7 2 (1 1 .5 ) 73 (1 1 .2 ) 7 0 (7 )
BM I (k g /m 2) 2 9 .9  (3 .9 ) 30 .4  (4 .2 ) 2 8 .9  (3 .1 )
.183
30 (5 .5 ) 30 (6 .2 ) 28 (5 )
Area o f pa in  (n o . o f p ixe ls) 12 ,7 6 6  (1 3 ,4 94 ) 15 ,0 1 2  (1 4 ,3 2 7 ) 8 ,7 4 7  (1 1 ,0 9 6 )
.017
8 ,2 7 2  (1 2 ,1 9 0 ) 1 0 ,3 1 4 (1 2 ,3 8 2 ) 5 ,8 1 6  (7 ,0 8 3 )
Pain d u ra tio n  (y) 7.5 (6 ) 6 .7  (5 .7 ) 9.1 (6 .3 )
.127
5 ( 1 0 ) 4 ( 1 0 .3 ) 6 ( 1 1 )
K e llg ren-Law rence grade  
(tib io fe m o ra l jo in t) , 
n (% )
.115
0 0 ( 0 ) 0 ( 0 ) 0 ( 0 )
1 0 ( 0 ) 0 ( 0 ) 0 ( 0 )
2 15 (2 8 .3 ) 7 (2 0 .5 ) 8 (4 2 .1 )
3 2 2 (4 1 .5 ) 11 (3 2 .3 ) 11 (5 7 .8 )
4 16 (3 0 .1 ) 8 (2 3 .5 ) 8 (4 2 .1 )
A h lback  grade
(p a te llo fe m o ra l jo in t) , 
n (% )
.231
1 3 (5 .6 ) 2 (5 .8 ) 1 (5 .2 )
2 1 9 (3 5 .8 ) 10 (2 9 .4 ) 1 9 (4 7 .3 )
3 30 (5 6 .6 ) 15 (4 4 .1 ) 15 (7 8 .9 )
4 1 (1 .8 ) 0 ( 0 ) 1 (5 .2 )
5 0 ( 0 ) 0 ( 0 ) 0 ( 0 )
°  O A = o s te o a rth r itis , IQ R = in te rq u a rtile  ra tio , B M I= b o d y  mass index. 
b  P  values re fe r to  p o te n tia l d iffe rences be tw een  m ale and  fem a le  pa rtic ipan ts .
the CSI score (rs=.456, P<.01); partici­
pants with higher scores on the CSI 
showed larger areas of pain.
Area of Pain and Clinical 
Symptoms
Higher scores on the pain subscale 
(rs=.325, P<.05) and stiffness subscale 
(rs= .341, P<.05) of the WOMAC were 
significantly associated with larger pain 
areas.
Discussion
Several methods for illustrating the area 
of pain in people with chronic knee OA 
pain have been used. We explored, for 
the first time, the utility of a novel digital 
device using 2-dimensional body charts 
for acquisition and analysis of the scores
obtained with pain drawings33 in a sam­
ple of individuals with chronic knee OA 
pain. Through a digital tablet using a 
user-friendly digital device, participants 
repotted their pattern of pain on a body 
chart. Other systems, such as the photo­
graphic knee pain map, have shown 
good validity and reliability for people 
with regional knee pain to identify its 
location.20
Area of Pain and Direct and 
Indirect Measures of CS
The results of this study showed a signif­
icant positive correlation between the 
area of pain and some direct and indirect 
measures of CS. On the one hand, a more 
expanded distribution of pain was corre­
lated with a lower PPT at a remote site
from the knee (ie, epicondyle). 
Increased pain sensitivity distantly from 
the knee may reflect widespread hyper­
algesia, thus providing evidence of CS in 
people with knee OA.9 1012 On the other 
hand, we found that a greater expansion 
of symptoms was associated with a 
higher degree of subjective CS pain 
descriptors as assessed with the CSI 
questionnaire. The CSI was recently 
shown to be a useful and valid instru­
ment for screening people with central 
sensitivity syndromes.58 In addition, indi­
viduals with knee OA pain who had pre­
operative high levels of comorbid cen­
trally mediated symptoms measured by 
the CSI showed severe pain and 
increased analgesic requirements and 
were at higher risk of persistent pain 
after total knee arthroplasty in the early 
postoperative period.59
Previous studies have established associ­
ations between the scores obtained with 
pain drawings and central pain mecha­
nisms, although in non-OA populations. 
For instance, a significant correlation 
between nonorganic pain drawings and 
higher scores with the Waddell’s nonor­
ganic physical signs was found in people 
with chronic low back pain.60 Waddell’s 
signs include physical signs or symptoms 
that are inconsistent with pathology and 
are suggestive of the presence of symp­
tom magnification or pain behavior.61 
Nonorganic pain drawings were defined 
as those with poorly defined pain pat­
terns and bizarre or nonanatomical pain 
areas.60 In addition, nonorganic pain 
drawings were associated with maladap­
tive psychosocial factors (ie, high levels 
of catastrophizing, anxiety, and depres­
sion) in people with chronic neck/shoul- 
der and lower back/lower limb pain62 
and those with chronic low back pain.63 
However, maladaptive psychosocial fac­
tors, including magnified symptom 
behavior as assessed with Waddell’s 
scale, provide no direct evidence for CS. 
Psychosocial factors were not included 
as essential criteria for classification of 
CS pain, as they also are prevalent in 
nociceptive and neuropathic pain.14
Based on results of the PD-Q, 13.2% of 
our sample had scores that correspond 
to likely neuropathic pain (>  19). These 
results are comparable to those reported
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Table 2.
Baseline Clinical Measurements0
Baseline M easurem ents  o f  P atients  
W ith  OA
A ll P artic ipan ts  (N  =  5 3 )  
X (SD) M ed ian  (IQ R)
Fem ale P artic ipan ts  (n = 3 4 )  
X (SD) M ed ian  (IQ R)
M a le  P artic ipan ts  (n =  19) 
X (SD) M ed ian  (IQ R) Pb
NPRS (0-10) 5.92 (17) 6.19 (17.2) 5.44 (15.8) .217
5.9 (22.5) 6.05 (27.3) 5.8 (20)
ROM active knee flexion (°) 115.5 (11.4) 113.9(9.8) 118.3 (13.5) .047
115.5 (10) 115 (8.7) 118.5 (9.2)
ROM active knee extension (°) -2 .41 (6.3) -3 .2  (6.7) -0 .9  (5.4) .30
- 2  (7.9) -2 .6  (7.96) -1 .6  (5.3)
Timed "Up Sr Co" Test (s) 11.4 (5.7) 13.4 (6.2) 7.9(1.6) .000
9.8 (5) 11.8 (5.5) 7.7 (2.6)
WOMAC (0-96) 49.4 (16.5) 54.1 (16.1) 40.9(13.9) .006
49 (25) 56 (24.5) 38 (20)
WOMAC pain subscale (0-20) 9.53(3.31) 10.6 (3.1) 7.6 (2.9) .001
10(5) 10(4) 7(3)
WOMAC stiffness subscale (0-8) 3.79 (2.11) 4.1 (2.3) 3.2 (1.7) .119
3(3) 4(3.8) 3(2)
WOMAC functional limitation scale (0-68) 36.09 (12.66) 39.4(12.5) 30.1 (10.7) .010
36(19) 42.5(19.8) 29 (17)
PCS (0-52) 23.77 (12.51) 27.2 (11.7) 17.7 (11.8) .012
25 (17) 26 (15.5) 20(19)
PVAQ (0-45) 28.66 (6.95) 28.6 (7.5) 28.8 (6) .773
28 (9) 28 (10.8) 29 (6.5)
CPAQ (0-120) 52.83 (18.26) 48.5(17.2) 60.6 (18) .022
52 (28) 47.5 (27.8) 64 (23)
TSK-11 (11-44) 33.68 (5.98) 35.1 (5.6) 31.2 (5.9) .029
34 (9) 35 (7.8) 32 (8)
CSI (0-100) 36.21 (15.62) 40.1 (16.6) 29.2 (10.8) .014
37 (23) 42 (22.5) 30 (19.5)
PD-Q (-1  to 38) 12.25 (6.3) 13.6 (6.6) 9.8 (5.1) .041
11 (8) 12(9) 10(8.5)
PPT knee (kg/cm2) 4.82 (2.62) 4(1.6) 6.2 (3.4) .018
4(3.15) 3.8 (2.5) 6.1 (4.9)
PPT epicondyle (kg/cm2) 4.03 (1.72) 3.7(1.5) 4.6 (2) .55
3.7 (2) 3.6 (1.3) 4.4 (2.4)
Knee TS (%) 40.44 (23.11) 40.53 (24.16) 40.28 (21.76) .853
43.75 (23.08) 42.46 (21.32) 44.44 (25.71)
Epicondyle TS (%) 43.39 (21.46) 3(1.7) 43.19 (17.79) .978
50 (32.14) 3(2) 50 (29.56)
Knee CPM (kg/cm2) -0 .4 4  (1.66) -0 .6  (1.6) -0 .1  (1.8) .054
0(2) 1 (1.5) 0.50 (1.5)
Epicondyle CPM (kg/cm2) -0 .4 3  (1.76) -0 .7 (1 .7 ) 0(1.8) .200
0(3) 1 (2) 0(2)
° OA=osteoarthritis, IQR=interquartile range, CPAQ=Chronic Pain Acceptance Questionnaire, CPM=conditioned pain modulation, CSI=Central Sensitization 
Inventory, NPRS=numeric pain rating scale, PCS=Pain Catastrophizing Scale, PD-Q=PainDETECT questionnaire, PPT=pressure pain threshold, PVAQ=Pain 
Vigilance and Awareness Questionnaire, ROM=range of motion, TS=temporal summation, TSK=Tampa Scale of Kinesiophobia, WOMAC=Western Ontario 
and McMaster Universities Arthritis Index.
b P values refer to potential differences between male and female participants.
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Figure 2.
Scatter plots illustrating the relationship between the area of pain and the pressure pain 
threshold (PPT) for both knee and epicondyle.
Table 3.
Spearman Correlation Coefficients Between 
Area of Pain (Total Pain Area Extracted 
From Dorsal and Ventral Body Views) 
Computed Using Pain Drawings and 
Measures of Central Sensitization and 
Clinical Symptoms for Entire Cohort of 
Individuals With Knee Osteoarthritis Pain 
(N = 53)°
M easu re /C lin ica l
Sym ptom s
C orre la tio n  W ith  
Pain A rea  (rs)
Direct measures of CS
PPT knee (kg/cm2) -.3 06*
PPT epicondyle 
(kg/cm2)
-.3 08*
Knee TS (%) -.0 18
Epicondyle TS (%) -.0 87
Knee CPM (kg/cm2) -.066
Epicondyle CPM 
(kg/cm2)
-.0 40
Indirect measures of CS
CSI .456**
PD-Q .266
Clinical symptoms
NPRS (0-10) .221
WOMAC .259
WOMAC pain 
subscale
.325*
WOMAC stiffness 
subscale
.341*
WOMAC functional 
limitation scale
.183
PCS .145
PVAQ .100
CPAQ -.1 95
TSK -.195
° CPAQ=Chronic Pain Acceptance Questionnaire, 
CPM=conditioned pain modulation, CSI=Central 
Sensitization Inventory, NPRS=numeric pain 
rating scale, PCS=Pain Catastrophizing Scale, 
PD-Q=PainDETECT questionnaire, PPT=pressure 
pain threshold, PVAQ=Pain Vigilance and 
Awareness Questionnaire, TS=temporal 
summation, TSK-11=11 -item Tampa Scale of 
Kinesiophobia, WOMAC=Western Ontario and 
McMaster Universities Arthritis Index.
* Correlation is significant at the .05 level 
(2-tailed). ** Correlation is significant at the .001 
level (2-tailed).
by Valdes and colleagues,64 where 14.8% 
of people with knee OA pain had likely 
neuropathic pain, and superior to the 
percentage obtained by Ohtori et al65 (ie, 
5.4%). Some studies have inferred CS 
based on neuropathic-like descriptors of 
symptoms.66-67 Contrary to what may 
have been expected, we did not find an 
association between the presence of a 
more expanded distribution of pain and 
self-reported neuropathic pain scores. 
This lack of association may have been 
due either to the small number of partic­
ipants with likely neuropathic pain or to 
the fact that we used the PD-Q and not 
the modified version of this question­
naire recently recommended for the OA 
pain population.66 Like the original 
PD-Q, the modified PD-Q comprises 9 
items but with some modifications 
adapted to people with OA, such as fram­
ing of questions to ask about symptoms 
“in or around" the worst knee, over a 
specific time frame. Also, the presence of 
more extended areas of pain in people 
with knee OA may reflect nonneuro- 
pathic CS rather than neuropathic pain, 
making the lack of association between 
the scores obtained from the pain draw­
ings and the PD-Q plausible.
No significant associations were 
observed between the area of pain and 
TS or the area of pain and CPM. Pain 
associated with knee OA is recognized as 
a complex phenomenon encompassing 
several mechanisms such as CS.68-69 The 
quantification of CS, in turn, is multidi­
mensional, including several objective 
QST techniques such as pain and toler­
ance thresholds, spatial summation, TS, 
or CPM.9-10-12 These QST techniques 
assess the same underlying biological 
concept (CS), but in its different mani­
festations related to the different aspects 
of sensitization. This factor could justify 
why the areas of pain as assessed with 
pain drawings were correlated with 
some pain biomarkers (eg, PPT) but not 
with other pain biomarkers of CS (eg, TS, 
CPM).
Area of Pain and Clinical 
Symptoms
A significant positive correlation 
between knee pain severity and stiffness 
and the area of pain reported by partici­
pants was observed. Although the area of 
pain, pain intensity, and stiffness are vari­
ables assessing different constructs, it 
could be expected that people with knee 
OA with more diffuse or more extended 
areas of pain would report higher pain 
intensity and stiffness scores. As shown 
in the pain frequency maps, the most 
common pattern of pain reported by our 
sample was anterior knee pain, in partic­
ular medial knee and peripatellar pain, 
which is in accordance with previous 
research. 19,20,25,26 interestingly, besides 
local knee symptoms, many participants 
also perceived enlarged and distant pain 
areas, as shown in Figure 115. This expan­
sion of pain to larger areas may reflect 
the presence of CS in these individuals.12
1204 ■  Physical Therapy Volume 96 Number 8 August 2016
Central Sensitization in Individuals With Symptomatic Knee Osteoarthritis
Although using an experimental pain 
design, Bajaj and colleagues^0 also 
showed significantly larger referred pain 
areas after intramuscular hypertonic 
saline infusion in individuals with knee 
OA compared with controls. Referred 
pain is a phenomenon attributed to 
CS.12-15 In addition, enlarged areas of 
pain were observed in individuals with 
knee OA pain, particularly in those with 
more persistent and severe symptoms.19
In our study, enlarged areas of pain were 
especially noticeable in women. This 
finding is consistent with previous 
research where the most sensitized 
groups of participants with knee OA pain 
contained more women than men.71’72 
In addition, a recent study73 looking at 
the moderator effect of sex in centrally 
mediated changes in people with knee 
OA pain showed a greater number of 
pain sites reported by women relative to 
men (P=.001).
Psychosocial variables were unrelated to 
the area of pain in our study. This lack of 
correlation is in accordance with previ­
ous research done in non-OA pain pop­
ulations, where no correlation between 
the area of pain and the individual psy­
chological state was demonstrated.74 
Indeed, a systematic review on pain 
drawings did not support the assumption 
that unusual or extensive pain drawings 
indicate disturbed psychological state.24
In this study, there are some method­
ological issues that should be consid­
ered. We did not collect information on 
the reliability or stability' of pain location 
over time in our sample. Reliability' was 
assumed based on a previous study using 
this method for pain drawings analysis in 
other chronic pain populations (eg 
chronic low back and neck pain).33 
Expanded distribution of pain (eg, 
referred pain) may be more commonly 
observed in those populations compared 
with individuals with knee OA pain, 
although no comparative data exist in 
that regard. Thus, our assumption may 
have influenced the results of this study. 
Future research, therefore, is warranted 
to evaluate the clinimetric properties of 
pain drawings in people with knee OA 
pain.
In addition, as positive and negative pre­
dictive values of pain drawings were not 
calculated and the study design was 
cross-sectional, firm conclusions about 
the predictive role of pain drawings on 
knee OA pain cannot be drawn. Future 
studies, for instance, could explore the 
possible association between the scores 
obtained with pain drawings and out­
come measures after treatment (ie, sur­
gery) in order to determine the real clin­
ical utility’ of pain drawings for people 
with knee OA pain. In this regard, Skou 
and colleagues22 found that individuals 
with pain after total knee arthroplasty 
demonstrated significantly more pain 
sites using a region-divided body chart 
compared with those without pain.
Screening for the presence of concurrent 
comorbidities (eg, hip joint or lumbar 
spine pathology, fibromyalgia) was not 
performed in this study. However, these 
comorbid conditions could have influ­
enced the patterns of pain described by 
participants. For instance, referred pain 
from the lumbar spine may have contrib­
uted to the posterior areas of symptoms, 
especially noted in female participants.
Despite the associations between direct 
and indirect measures of CS and the area 
of pain, it must be noted that most asso­
ciations were not statistically significant. 
Only 2 (ie, PPT and CSI) of the 6 mea­
sures of CS were significantly associated 
with an expanded distribution of pain. In 
addition, even though positive associa­
tions were observed, the strength of 
those associations was low, as reflected 
by the small amount of the variance of CS 
(ie, 9%) explained by the areas of pain.
Examining TS directly before measure­
ment of CPM is a challenge, as the TS 
measurement could potentially have an 
effect on the results of CPM testing. 
However, we performed the measure­
ment of CPM 5 minutes after the TS pro­
cedure, following the protocol described 
by others.37 Temporal summation is 
short-lasting; the effects last for no more 
than a couple of seconds to minutes after 
stimulus application.3 Therefore, a 
5-minute washout period between pro­
cedures was deemed appropriate to pre­
clude a carryover effect.
In conclusion, this study has shown that 
the area of pain reported by individuals 
with knee OA pain is associated with 
some measures of CS. Given the signifi­
cant role that CS plays in a subgroup of 
people with knee OA pain and that CS 
can mediate treatment responses (ie, 
after surgery75-76), classification of peo­
ple with knee OA pain in terms of pain 
mechanisms is a research priority.6-23-77 
However, as laboratory equipment that is 
costly and not widely available is usually 
necessary for diagnosis, identification of 
CS is clinically challenging. In this 
regard, pain drawings may constitute an 
easy and cheap way for the early identi­
fication of CS in people with knee OA 
pain. Clinicians should be attentive for 
individuals showing extended areas of 
pain, as this may be an indicator of CS. 
However, further evaluation of the reli­
ability and validity of pain area reported 
on pain drawings in this population is 
needed before its use can be advocated 
in clinical practice.
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